Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer

Published:2017-06 Issue:2 Volume:2017 Page:2141-2148
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Bardia Aditya¹,Mayer Ingrid A.¹,Diamond Jennifer R.¹,Moroose Rebecca L.¹,Isakoff Steven J.¹,Starodub Alexander N.¹,Shah Nikita C.¹,O’Shaughnessy Joyce¹,Kalinsky Kevin¹,Guarino Michael¹,Abramson Vandana¹,Juric Dejan¹,Tolaney Sara M.¹,Berlin Jordan¹,Messersmith Wells A.¹,Ocean Allyson J.¹,Wegener William A.¹,Maliakal Pius¹,Sharkey Robert M.¹,Govindan Serengulam V.¹,Goldenberg David M.¹,Vahdat Linda T.¹

Affiliation:

1. Aditya Bardia, Steven J. Isakoff, and Dejan Juric, Massachusetts General Hospital Cancer Center; Aditya Bardia, Steven J. Isakoff, Dejan Juric, and Sara M. Tolaney, Harvard Medical School; Sara M. Tolaney, Dana-Farber Cancer Institute, Boston, MA; Ingrid A. Mayer, Vandana Abramson, and Jordan Berlin, Vanderbilt-Ingram Cancer Center, Nashville, TN; Jennifer R. Diamond and Wells A. Messersmith, University of Colorado Cancer Center, Aurora, CO; Rebecca L. Moroose and Nikita C. Shah, University of Florida...

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2016.70.8297.2017.2.test

Reference41 articles.

1. Past, Present, and Future Challenges in Breast Cancer Treatment

2. Global cancer statistics, 2012

3. Molecular portraits of human breast tumours

4. Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sacituzumab govitecan in triple-negative breast cancer: from bench to bedside, and back;Frontiers in Immunology;2024-08-15

2. Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing Strategies;Journal of Clinical Oncology;2023-07-20

3. Biocompatible magnetic hydroxyapatite Fe3O4-HAp nanocomposites for T1-magnetic resonance imaging guided photothermal therapy of breast cancer;Materials Today Communications;2022-06

4. Structural insights into the cis and trans assembly of human trophoblast cell surface antigen 2;iScience;2021-10

5. Corneal features in trastuzumab emtansine treatment: not a rare occurrence;Breast Cancer Research and Treatment;2019-02-28